Navigation Links
Golden Meditech Announces Plan to Issue Taiwan Depository Receipts
Date:8/31/2010

Golden Meditech Announces Plan to Issue Taiwan Depository Receipts -- HONG KONG, Aug. 31 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Stock Offering Click to view news release full screen  

Golden Meditech Announces Plan to Issue Taiwan Depository Receipts

   

Reaping the Fruit of Economic Cooperation Framework Agreement

HONG KONG, Aug. 31 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings Limited ("Golden Meditech" or the "Group," 801.HK), China's leading integrated healthcare enterprise, is pleased to announce that the Group is considering to list its shares on the Taiwan Stock Exchange through the issuance of Taiwan Depositary Receipts ("TDRs"), and has appointed Polaris Securities Co., Ltd. as the financial advisor for the proposed listing. The Group will become the first integrated healthcare company listed on Taiwan's stock market should the company proceed with the proposed TDR issuance upon obtaining relevant regulatory approval.

Mr. Kam Yuen, Chairman and Chief Executive Officer of the Group said that China's ongoing medical reform and the newly launched preferential trade agreement under Economic Cooperation Framework Agreement ("ECFA") has created a perfect window to encourage stronger strategic collaborations between Taiwan and China, amongst which, the sharing of corporate and human resources, etc.

Mr. Kam said that Taiwan's well developed healthcare insurance system as well as its world-class healthcare corporations can help to strengthen the Group's existing medical devices and healthcare services businesses in China. Citing closer collaborations between Taiwan and China which opens up numerous investment opportunities, the Group would like to leverage this opportunity to strengthen and speed up its business development initiatives, including knowledge-sharing of Taiwan's experience in the development of its healthcare industries, with similar attributes to China's development in many ways.

Based on the track records of other TDR issuances, Mr. Kam is confident that the Group will be able to enhance the liquidity of its shares while broadening its shareholder base, and enable quality investors from Taiwan to invest in Group's shares while promote the Group's corporate image in Taiwan.

About Golden Meditech Holdings Limited

Golden Meditech Holdings Limited is China's leading integrated-healthcare device and service operator, and the first medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEx). Thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities Golden Meditech has, over the years, established itself as a first-mover in China's healthcare industry with dominant positions in medical devices and healthcare services markets. Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.

For enquiries, please contact: Golding Meditech Holdings Limited Investor Relations Department Add: 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong Tel: +852-3605-8180 Fax: +852-3605-8181 Email: ir@goldenmeditech.com
'/>"/>

SOURCE Golden Meditech Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Golden Meditech Announces Annual Results for FY 2009/10
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Mass. , Feb. 27, 2017  Infinity Pharmaceuticals, ... at the Cowen and Company 37 th Annual ... p.m. ET in Boston, MA. ... on the Investors/Media section of Infinity,s website at ... following the event. About Infinity,Infinity is an ...
(Date:2/27/2017)... , Feb. 27, 2017  Impax Laboratories, Inc. (NASDAQ: IPXL ) ... conferences. Raymond James and Associates, 38 ... 6, 2017 in Orlando, FL. ... a.m. ET on March 7, 2017 in Boston, MA. ... March 16, 2017 in Miami, FL. ...
(Date:2/27/2017)... February 27, 2017 A recent research report ... marijuana market alone is expected to reach a value of $55.8 ... along with 28 states have legalized marijuana for medical uses. ... Florida , North Dakota , ... approved to use the drug in medical applications such as chemotherapies ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... ... environs, is proud to announce an upgrade to the company's Yelp listing. Bay ... page on topics as diverse as Platelet Rich Plasma (PRP) therapy, hair transplantation ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... the lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for ... analysis. , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... scheduling, and reporting for healthcare organizations. This comprehensive and customizable solution empowers ... process. StaffBridge technology improves staffing efficiency, maximizes resource allocation, collects critical reporting ...
(Date:2/25/2017)... ... February 25, 2017 , ... FCPX users now have the ... Pixel Film Studios. With ProSharpen Color users have total control over sharpening amount, sharpening ... color range. With color spectrum tools users can visually see the color range effected ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... education, networking and recognition opportunities as well as advocacy for the state and ... NJ on February 23. The Council's Innovation Forecast event highlights innovation throughout ...
Breaking Medicine News(10 mins):